Merrimack Pharmaceuticals
(NASDAQ:MACK)
$14.68
0[0.00%]
Last update: 5:22PM Get Real Time Here

Merrimack Pharmaceuticals Stock (NASDAQ:MACK), Quotes and News Summary

Merrimack Pharmaceuticals Stock (NASDAQ: MACK) stock price, news, charts, stock research, profile.

Open$14.670
Close-
Volume / Avg.28.298K / 121.575K
Day Range14.670 - 14.700
52 Wk Range11.530 - 15.890
Market Cap$213.326M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
53
Short Interest
7.08%
Days to Cover4.97
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
About Merrimack Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercialize...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MACK
OTLK

FAQ

Q

How do I buy Merrimack Pharmaceuticals (MACK) stock?

A

You can purchase shares of Merrimack Pharmaceuticals (NASDAQ: MACK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Merrimack Pharmaceuticals's (MACK) competitors?

Q

What is the target price for Merrimack Pharmaceuticals (MACK) stock?

A

The latest price target for Merrimack Pharmaceuticals (NASDAQ: MACK) was reported by Baird on Monday, October 22, 2018. The analyst firm set a price target for 4.00 expecting MACK to fall to within 12 months (a possible -72.77% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Merrimack Pharmaceuticals (MACK)?

A

The stock price for Merrimack Pharmaceuticals (NASDAQ: MACK) is $14.69 last updated Today at April 16, 2024 at 12:11 PM EDT.

Q

Does Merrimack Pharmaceuticals (MACK) pay a dividend?

A

A quarterly cash dividend of $0.50 per share of Class A Common Stock. The quarterly cash dividend was payable on December 23, 2019 to stockholders of record on December 13, 2019.

Q

When is Merrimack Pharmaceuticals (NASDAQ:MACK) reporting earnings?

A

Merrimack Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Q

Is Merrimack Pharmaceuticals (MACK) going to split?

A

There is no upcoming split for Merrimack Pharmaceuticals.

Q

What sector and industry does Merrimack Pharmaceuticals (MACK) operate in?

A

Merrimack Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch